{"id":"https://openalex.org/W205507086","doi":null,"title":"Use of retinoids in the treatment of psoriasis.","display_name":"Use of retinoids in the treatment of psoriasis.","alternate_titles":[],"publication_year":1989,"publication_date":"1989-05-01","ids":{"openalex":"https://openalex.org/W205507086","mag":"205507086","pmid":"https://pubmed.ncbi.nlm.nih.gov/2663325"},"language":"en","primary_location":{"id":"pmid:2663325","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2663325","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacy","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W205507086"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033552471","display_name":"Eric W. Warren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E W Warren","raw_affiliation_strings":["University of Michigan Hospitals, Ann Arbor 48109-0008"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan Hospitals, Ann Arbor 48109-0008","institution_ids":["https://openalex.org/I4210114445"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069732197","display_name":"Ujjaini Khanderia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"U Khanderia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2853,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.49034186,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":95},"biblio":{"volume":"8","issue":"5","first_page":"344","last_page":"351"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.968999981880188},{"id":"https://openalex.org/keywords/retinoids","display_name":"retinoids","score":0.9860000014305115},{"id":"https://openalex.org/keywords/etretinate","display_name":"etretinate","score":0.9959999918937683},{"id":"https://openalex.org/keywords/acitretin","display_name":"acitretin","score":1.0},{"id":"https://openalex.org/keywords/pustular-psoriasis","display_name":"pustular psoriasis","score":0.9279999732971191},{"id":"https://openalex.org/keywords/plaque-psoriasis","display_name":"plaque psoriasis","score":0.7799999713897705},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.7080000042915344},{"id":"https://openalex.org/keywords/teratogenicity","display_name":"teratogenicity","score":0.8989999890327454},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.9110000133514404},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7979999780654907},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.4959999918937683},{"id":"https://openalex.org/keywords/puva","display_name":"PUVA","score":0.8479999899864197},{"id":"https://openalex.org/keywords/corticosteroids","display_name":"corticosteroids","score":0.8299999833106995},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.8830000162124634},{"id":"https://openalex.org/keywords/anthralin","display_name":"anthralin","score":0.8379999995231628},{"id":"https://openalex.org/keywords/coal-tar","display_name":"coal tar","score":0.968999981880188}],"concepts":[{"id":"https://openalex.org/C2776705134","wikidata":"https://www.wikidata.org/wiki/Q554297","display_name":"Etretinate","level":3,"score":0.9916242361068726},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.9138185977935791},{"id":"https://openalex.org/C2778496887","wikidata":"https://www.wikidata.org/wiki/Q341500","display_name":"Acitretin","level":3,"score":0.8993819952011108},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8875788450241089},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7743145227432251},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.689030647277832},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.6711071133613586},{"id":"https://openalex.org/C2778397455","wikidata":"https://www.wikidata.org/wiki/Q50429865","display_name":"Antimetabolite","level":3,"score":0.49502962827682495},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.48999157547950745},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.41375818848609924},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19454917311668396}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012176","descriptor_name":"Retinoids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:2663325","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2663325","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacy","raw_type":"Journal Article"},{"id":"mag:205507086","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2663325","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2072685025","https://openalex.org/W2018613851","https://openalex.org/W2343576285","https://openalex.org/W2120296766","https://openalex.org/W1978122993","https://openalex.org/W2460657334","https://openalex.org/W2140865108","https://openalex.org/W2091657880","https://openalex.org/W2619666191","https://openalex.org/W1964306038"],"abstract_inverted_index":{"The":[0,61,123],"limitations":[1],"of":[2,21,35,87,104,128,134,138,144,152,163,187,209,221,224,236,240],"conventional":[3],"therapy":[4,42,220],"for":[5,30,101,120,219],"psoriasis":[6,31,234],"are":[7,26,64,74,130],"reviewed,":[8],"and":[9,18,23,37,47,51,90,141,212],"the":[10,71,85,135,161,183,237],"pharmacology,":[11],"pharmacokinetics,":[12],"clinical":[13],"efficacy,":[14],"adverse":[15,78,126,164,242],"effects,":[16],"dosing":[17],"therapeutic":[19,115],"monitoring":[20],"etretinate":[22,129,196],"other":[24,118,150],"retinoids":[25],"described.":[27],"Traditional":[28],"treatments":[29,73,119],"include":[32],"topical":[33,62],"application":[34],"anthralin":[36],"coal":[38],"tar":[39],"ointments;":[40],"systemic":[41,48,52,72],"with":[43,55,76,149,179],"corticosteroids":[44,156],"or":[45,49,157],"methotrexate;":[46,50],"psoralens":[53],"combined":[54],"exposure":[56],"to":[57,69,96,176,207,215,231],"ultraviolet":[58],"light":[59],"(PUVA).":[60],"therapies":[63,100],"beneficial":[65],"but":[66],"aesthetically":[67],"displeasing":[68],"patients;":[70],"associated":[75],"severe":[77,102,222],"reactions.":[79],"Etretinate":[80,89,166,211,226],"provides":[81],"another":[82],"option":[83],"in":[84,147],"treatment":[86],"psoriasis.":[88,108,122,225],"acitretin,":[91],"an":[92],"investigational":[93],"retinoid,":[94],"appear":[95,214],"be":[97,216,229],"effective":[98,218],"oral":[99],"variants":[103,223],"psoriasis,":[105],"especially":[106],"pustular":[107],"Retinoids":[109],"generally":[110],"do":[111],"not":[112,228],"offer":[113],"substantial":[114],"advantages":[116],"over":[117],"chronic-plaque":[121],"most":[124],"common":[125],"effects":[127],"cheilitis,":[131],"alopecia,":[132],"desquamation":[133],"skin,":[136],"drying":[137],"mucous":[139],"membranes,":[140],"pruritus.":[142],"Use":[143],"low-dose":[145],"etretinae":[146],"combination":[148],"forms":[151],"therapy,":[153],"such":[154],"as":[155],"PUVA,":[158],"may":[159],"minimize":[160],"frequency":[162],"effects.":[165,243],"is":[167,174,205],"a":[168,190],"known":[169],"teratogen.":[170],"Its":[171,202],"elimination":[172,193],"half-life":[173,194],"prolonged":[175],"100-120":[177],"days":[178],"long-term":[180],"use.":[181],"Acitretin,":[182],"carboxylic":[184],"acid":[185],"derivative":[186],"etretinate,":[188],"has":[189],"much":[191],"shorter":[192],"than":[195],"(50":[197],"hours":[198],"after":[199],"multiple":[200],"doses).":[201],"adverse-effect":[203],"profile":[204],"similar":[206],"that":[208],"etretinate.":[210],"acitretin":[213],"clinically":[217],"should":[227],"used":[230],"treat":[232],"mild":[233],"because":[235],"high":[238],"incidence":[239],"serious":[241]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W205507086","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
